ARM Innovation Hub
Advertisement: Wild Knight Vodka
Advertisement EY mid banner
Advertisement: Mogrify
Advertisement: RSM
Mid banner advertisement: BDO
RealVNC mid banner careers
Advertisement: Bradfield Centre mid
RealVNC mid-banner general
Barr Ellison Solicitors – commercial property
Advertisement: Cambridge Network
Advertisement: TTP
4 November, 2011 - 12:59 By News Desk

Preventive and harm reduction effects of Quinazolinone-derivatives

A Hungarian University has developed quinazolinone-derivatives and their use for preparation of pharmaceutical compositions having poly (ADP-ribose) polymerase (PARP) enzyme inhibitory effect. This method decrease the severity of infarction, type 2 diabetes and other chronic  illnesses. The institute is looking for industrial or reserach partners for license agreement or R&D agreement opportunity.Ref: 11 HU 50S5 3MVX

Add new comment

Newsletter Subscription

Stay informed of the latest news and features